Pharmaceutical Companies Face $9B In Punitive Damages For Concealing Cancer Risks

Pharmaceutical Companies Face $9B In Punitive Damages For Concealing Cancer Risks

A Japanese drug maker is facing higher punitive damages for allegedly concealing the cancer risks associated with a diabetes drug than those dished out in the past by federal juries. [More]